Towards Healthcare
Rheumatoid Arthritis Drugs Market Size and Companies Report (2024 - 2033)

Rheumatoid Arthritis Drugs Market Size Envisioned at USD 27.38 Billion by 2033

The report covers Rheumatoid Arthritis Drugs Market Companies and Segments by drug type including pharmaceuticals such as NSAIDs, analgesics, DMARDs and glucocorticoids, as well as biopharmaceuticals like biologics, TNF-α antagonists, T-cell inhibitors, CD20 antigens, JAK inhibitors, anti-IL6 biologics and biosimilars, with CD20 antigens. Distribution channels span hospital, retail and online pharmacies. Route of administration includes oral, parenteral and topical applications. The report offers the value (in USD Billion) for the above segments.

Introduction

  • Research Objective
  • Scope of the Study
  • Definition and Taxonomy

Research Methodology

  • Research Approach
  • Data Sources
  • Assumptions

Executive Summary

  • Synopsis
  • Analyst Recommendations

Market Overview 

  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Value Chain Analysis
    • Raw Material Sourcing
    • Manufacturing Process
    • Logistics & Transportation
    • Buyer Preferences
  • Trends
    • Market Trends
    • Technological Trends
  • Porter’s Five Forces Analysis
    • Bargaining Power of Suppliers
    • Bargaining Power of Buyers
    • Threat of Substitute
    • Threat of New Entrants
    • Degree of Competition
  • PESTLE Analysis for 5 Leading Countries
    • Regulatory Framework for Leading Countries/Regions
    • Supply Demand Analysis
    • Production & Consumption Statistics
    • Export Import Statistics
    • Price Trend Analysis

Global Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • Global Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • Global Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical
  • Global Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Geography (2021 – 2033)
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East and Africa

North America Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • North America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • North America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • North America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical

Europe Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • Europe Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • Europe Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Europe Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical

Asia Pacific Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • Asia Pacific Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • Asia Pacific Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Asia Pacific Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical

Latin America Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • Latin America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • Latin America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Latin America Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical

Middle East and Africa Rheumatoid Arthritis Drugs Market Assessment

  • Overview
  • Middle East and Africa Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Drug Type (2021 – 2033)
    • Pharmaceuticals
      • NSAIDs
      • Analgesics
      • DMARDs
      • Glucocorticoids
    • Biopharmaceuticals
      • Biologics
        • TNF-α Antagonists
        • T-cell Inhibitors
        • CD20 Antigen
        • JAK Inhibitors
        • Anti-IL6 Biologics
      • Biosimilars
        • CD20 Antigen
        • TNF-α Antagonists
  • Middle East and Africa Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Distribution Channel (2021 – 2033)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Middle East and Africa Rheumatoid Arthritis Drugs Market Size Value (US$) and Volume (Billion Tons), by Route of Administration (2021 – 2033)
    • Oral
    • Parenteral
    • Topical

Company Profiles

  • Boehringer Ingelheim GmbH
    • Company Overview
    • Geographic Footprints
    • Financial Performance
    • Product Portfolio
    • SWOT Analysis
    • R&D Efforts
    • Recent Developments & Strategic Collaborations
      • Product Launch/M&A/Technical Collaboration
  • AbbVie
  • Novartis
  • Pfizer Inc
  • Bristol Mayers Squib
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Regeneron Pharmaceuticals, Inc
  • Amgen, Inc.
  • Merck KGaA

Conclusion & Recommendations

  • Insight Code: 5122
  • No. of Pages: 150+
  • Format: PDF/PPT/Excel
  • Published: May 2024
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2022
  • Base Year: 2023
  • Estimated Years: 2024-2033

About The Author

Deepa has certified the degree of Master’s in Pharmacy in the Pharmaceutical Quality Assurance department from Dr D.Y. Patil College of Pharmacy. Her research is focused on the healthcare industry. She is the author or co-author of four Review Articles, which include Solid dispersion a strategic method for poorly soluble drugs and solubility improvement techniques for poorly soluble drugs, Herbal Drugs Used In Treatment Of Cataracts, Nano sponges And Their Application in Cancer Prevention and Ayurvedic Remedies of Peptic ulcer. She has also published a Research Article on the Formulation and Evaluation of Mucoadhesive Tablets of Miconazole cocrystal which was published in GIS Science Journal Volume 9 Issue 8. Her passion for secondary research and desire to take on the challenge of solving unresolved issues is making her flourish is the in the research sector.

FAQ's

The primary treatments for rheumatoid arthritis typically include disease-modifying antirheumatic drugs (DMARDs) such as methotrexate, corticosteroids, NSAIDs to reduce inflammation and manage symptoms, and biologic agents targeting specific immune pathways. These drugs aim to alleviate pain, reduce inflammation, and slow the progression of joint damage.

The primary hurdle in the rheumatoid arthritis drug market is the high cost of medications, which can limit access to treatment for some patients. Additionally, there are challenges related to potential side effects and the need for ongoing monitoring and management of the disease.

Increasing prevalence of rheumatoid arthritis and innovation in rheumatoid arthritis therapy.

National Institute of Health, World Health Organization, Center for Disease Control and Prevention, ScienceDirect, Wolters Kluwer.

Warning: include(report-detail-graphs.php): failed to open stream: No such file or directory in /home/thealthcre/public_html/report-toc.php on line 509

Warning: include(): Failed opening 'report-detail-graphs.php' for inclusion (include_path='.:/opt/cpanel/ea-php74/root/usr/share/pear') in /home/thealthcre/public_html/report-toc.php on line 509